medigraphic.com
SPANISH

Revista de Enfermedades Infecciosas en Pediatría

Órgano Oficial de la Asociación Mexicana de Infectología Pediátrica y la SLIPE.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2013, Number 103

<< Back Next >>

Rev Enfer Infec Pediatr 2013; 26.27 (103)

Spanish recommendations for monitoring of pediatric patients infected with Human Immunodeficiency Virus. Part 1

Soler-Palacín P
Full text How to cite this article

Language: Spanish
References: 13
Page: 241-245
PDF size: 296.99 Kb.


Key words:

No keywords

ABSTRACT

No abstract


REFERENCES

  1. Ruby Fayorsey, MD, MPH Elaine J Abrams, MD. Pediatric HIV/AIDS Care& Treatment. The International Center for AIDS Care & Treatment Programs (ICAP). Columbia University Mailman School of Public Health, 2006.

  2. Zeichner Steven L, Read Jennifer S. Textbook of pediatric HIV care. Cambridge University Press, 2004.

  3. Mofenson LM, Korelitz J, Meyer WA 3rd et al. The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group. J Infect Dis 1997; 175:1029-38.

  4. Haas DW. Can responses to antiretroviral therapy be improved by therapeutic drug monitoring? Clin Infect Dis 2006; 42:1197-9.

  5. Martin S, Elliott-DeSorbo DK, Wolters PL et al. Patient, caregiver and regimen characteristics associated with adherence to highly active antiretroviral therapy among HIV-infected children and adolescents. Pediatr Infect Dis J 2007; 26:61-7.

  6. Arpadi SM. Growth failure in HIV infected children. WHO. Available at: http://www.who.int/nutrition/topics.

  7. Sacktor N, Lyles RH, Skolasky R, et al. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology 2001; 56: 257-60.

  8. Letendre S, Marquie-Beck J, Capparelli E, et al. Validation of the CNS Penetration- Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 2008; 65: 65-70.

  9. Whitcup SM, Robinson MR. Ocular manifestations of HIV in the pediatric population. In: Pediatric AIDS. 3rd Edition. Pizzo PA, Wilfert CA. Baltimore; Williams & Wilkins, 1998.

  10. Flaitz C, Wullbrandt B, Sexton J, et al. Prevalence of orodental findings in HIV infected Romanian children. Pediatr Dent. 2001; 23:44-50.

  11. Zar HJ. Pneumonia in HIV-infected and uninfected children in developing countries - Epidemiology, clinical features and management. Curr Opin Pulm Med 2004; 10: 176-82.

  12. Starc TJ, Lipshultz SE, Easley KA, et al. Incidence of cardiac abnormalities in children with human immunodeficiency virus infection: The prospective P2C2 HIV study. J Pediatr 2002; 141:327-34.

  13. Miller TL, Orav EJ, Lipshultz SE, et al. Risk factors for cardiovascular disease in children infected with human immunodeficiency virus-1. J Pediatr 2008; 153:491-7.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Enfer Infec Pediatr. 2013;26.27